Traditional Chinese medicine for treating bronchial asthma

Abstract

The invention relates to a traditional Chinese medicine for treating bronchial asthma. The traditional Chinese medicine is prepared from following raw material medicines comprising, by weight, 8 parts of inula japonica, 10 parts of bamboo shavings, 9 parts of cynanchum glaucescens, 6 parts of aster tataricus, 13 parts of asparagus cochinchinensis and 9 parts of semen raphani. A clinical experiment proves that the traditional Chinese medicine can treat the bronchial asthma safely and efficiently.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine for treating bronchial asthma. Background technique [0002] Bronchial asthma is a chronic inflammatory disease of the airways that involves a variety of cells (such as eosinophils, mast cells, T lymphocytes, neutrophils, airway epithelial cells, etc.) and cell components. This chronic inflammation leads to the generation of airway hyperresponsiveness, usually widespread and variable reversible airflow limitation, and causes recurrent symptoms such as wheezing, shortness of breath, chest tightness or coughing, often at night and / or in the early morning, Most patients can be relieved spontaneously or after treatment. The clinical manifestations are typical bronchial asthma with repeated attacks of chest tightness, wheezing, dyspnea, cough and other symptoms. Before the attack, there are often aura symptoms such as nasal congestion, sneezing, and it...

AI Technical Summary

Problems solved by technology

The course of the disease is long and the onset is random, which poses a great threat to the life safety of patients

[0004] Bronchial asthma is a polygenic hereditary disease with obvious familial aggregation tendency. Its occurrence is affected by both genetic factors and environmental factors. Currently, western medicines include bronchodilator drugs: β 2 Receptor agonists, theophylline, anti-inflammatory drugs: glucocorticoids, leukotriene regulators, sodium cromoglycate and sodium nitrate, anti-IgE monoclonal antibodies, antihistamines, etc., but their therapeutic effects are all short-lived and side effects